Treatment with artificial β-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes

F. L. Dunn, P. B. Carroll, W. F. Beltz

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

The effect of restoration of euglycemia with the artificial β-cell (Biostator GCIIS) on triglyceride metabolism was studied in seven normolipidemic patients with type I diabetes mellitus. Very-low-density lipoprotein triglyceride (VLDL-TG) transport was determined with [3H]glycerol as an endogenous precursor of VLDL-TG; the resultant kinetic data were evaluated by multicompartmental analysis. Studied of triglyceride metabolism were performed in diabetic patients taking their usual dose of subcutaneous insulin (control study) and after 72 h of euglycemia with the artificial β-cell (Biostator study). Treatment with the artificial β-cell resulted in a decrease in mean (±SE) 24-h plasma glucose levels from 199 ± 9 to 123 ± 7 mg/dl and an increase in mean plasma free-insulin levels from 12.3 ± 1.9 to 27.6 ± 4.2 μU/ml (P<.05). These changes were accompanied by a decrease in mean plasma TG levels from 134 ± 29 to 88 ± 15 mg/dl (P<.05). Kinetic studies demonstrated that the change in plasma triglyceride levels was primarily due to a decrease in VLDL-TG transport (i.e., synthesis), which fell from 1.17 ± 2.5 mg·h-1·kg-1 ideal wt during the control study to 7.5 ± 2.0 mg·h-1·kg-1 ideal wt during the Biostator study (P<.05). There was no significant change in fractional catabolic rates of VLDL-TG between the two studies (0.35 ± .05 vs. 0.38 ± .07 h-1). Thus, our data suggest that the decrease in plasma TG levels after short-term restoration of euglycemia with the artificial β-cell is due to a decrease in VLDL-TG synthesis.

Original languageEnglish (US)
Pages (from-to)661-666
Number of pages6
JournalDiabetes
Volume36
Issue number5
StatePublished - Dec 1 1987

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Treatment with artificial β-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes'. Together they form a unique fingerprint.

  • Cite this